Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "RET"

1727 News Found

Mardamed unveils 15,000 sq. ft. HeX Centre integrating healthcare with everyday retail
Healthcare | June 25, 2026

Mardamed unveils 15,000 sq. ft. HeX Centre integrating healthcare with everyday retail

The company aims to make preventive and specialist healthcare as accessible as everyday retail experiences


Eli Lilly India launches Tanstrive for RET-altered cancers
Drug Approval | June 25, 2026

Eli Lilly India launches Tanstrive for RET-altered cancers

CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours


European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment
Drug Approval | June 24, 2026

European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment

Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data


Teva submits FDA application for experimental Tourette syndrome treatment ecopipam
Drug Approval | June 23, 2026

Teva submits FDA application for experimental Tourette syndrome treatment ecopipam

The filing is backed by positive Phase 3 results recently published in JAMA Neurology


Alembic secures USFDA nod for Tretinoin Cream strengthening generics portfolio
Drug Approval | June 14, 2026

Alembic secures USFDA nod for Tretinoin Cream strengthening generics portfolio

The approval clears the company to market a generic version that is therapeutically equivalent to Retin-A Cream


Remidio secures Gates Foundation grant to advance AI-powered retinal screening
Healthcare | June 10, 2026

Remidio secures Gates Foundation grant to advance AI-powered retinal screening

Funding will support the expansion of Remidio’s Oculomics platform to identify early signs of pre-eclampsia, anemia and gestational diabetes through retinal imaging, targeting underserved communities


Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce
Policy | June 10, 2026

Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce

Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports


Eli lilly’s retatrutide delivers up to 30% weight loss in phase 3 trial
Clinical Trials | May 23, 2026

Eli lilly’s retatrutide delivers up to 30% weight loss in phase 3 trial

Clears major obesity endpoints at 80 weeks


Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial
News | May 21, 2026

Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial

All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks


Even Healthcare receives IRDAI approval to offer retail health insurance products
Healthcare | May 06, 2026

Even Healthcare receives IRDAI approval to offer retail health insurance products

The approval enables the company to directly sell health insurance plans to individuals and families while integrating its managed healthcare delivery model into retail offerings